Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11524 posts found.

26629351446_42eeafa009_b_1

UK Health Secretary says no tactics will be “off the table” in dealing with coronavirus

March 2, 2020 Sales and Marketing Chinese Coronavirus, MERS, Sars, Wuhan Coronavirus, coronavirus

British Health Secretary Matt Hancock has said nothing will be “off the table” in tackling the coronavirus as cases in …
News
martin_shkreli_2016

FDA approves first generic version of Shkreli-hiked toxoplasmosis drug Daraprim

March 2, 2020 Sales and Marketing Cerovene, Daraprim, FDA, Martin Shkreli, generics, pharma

The FDA has awarded approval to the first generic medicine for the treatment of toxoplasmosis, authorising Cerovene’s version of Daraprim …
News
1024px-u

Sanofi set to pay $11.9 million to resolve kickback probe, US Justice Department announces

March 2, 2020 Sales and Marketing Co pays, Justice department, Medicaid, Medicare, Sanofi, insurance

The Justice Department have announced that Sanofi SA have agreed to pay $11.85 million to resolve allegations it used a …
News
170124-f-ds634-005

Experimental drug could treat dyskinesia in people with Parkinson’s

March 2, 2020 Sales and Marketing Parkinson's, Parkinson's disease, dyskinesia, spasms

Results from a new study researching treatment for dyskinesia has offered hope that it may be treatable in people with …
News
takeda_usa_pharmaceuticals_u

Takeda’s subcutaneous vedolizumab nabs CHMP nod for maintenance of ulcerative colitis and Crohn’s

February 28, 2020 Medical Communications, Sales and Marketing CHMP, EMA, Takeda, vedolizumab

Takeda’s subcutaneous formulation of its gut-selective biologic vedolizumab has secured recommendation from the European Medicines Agency’s (EMA) Committee for Medicinal …
News
top_10_image_2_1

Top Ten most popular articles on Pharmafile.com this week

February 28, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Chinese Coronavirus, Johnson and Johnson, Wuhan Coronavirus, coronavirus

The coronavirus continues to spread across the globe as the US launch their first trials for Gilead’s ebola drug remdesivir …
News
fda2outsideweb

Acacia Pharma secures first FDA approval with Barhemsys for postoperative nausea and vomiting

February 28, 2020 Medical Communications, Sales and Marketing Acacia, FDA, UK, US, pharma

UK-based Acacia Pharma has secured its first US approval with the FDA’s decision to authorise Barhemsys (amisulpride injection) for the …
News
pharmafocus_march_2020_cover

The March 2020 issue of Pharmafocus is available to read free online now!

February 27, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing England, Pharmafocus, UK, mumps, pharma, pharmacovigilance, type 2 diabetes

The latest monthly edition of Pharmafocus, the March issue, is available to read for free online now! The coronavirus continues …
News
lilly_entrance_web

FDA advisory committee narrowly backs Eli Lilly’s Cyramza combo for metastatic EGFR+ NSCLC

February 27, 2020 Sales and Marketing Eli Lilly, FDA, cyramza, pharms

Eli Lilly’s Cyramza (ramucirumab) has edged closer to US approval after it scored a recommendation from the FDA’s Oncologic Drugs …
News
celgene_building

NICE recommends Celgene’s Revlimid combo for follicular lymphoma

February 27, 2020 Sales and Marketing Cancer, Celgene, NICE, Revlimid, follicular lymphoma, pharma

NICE has chosen to recommend Celgene’s Revlimid (lenalidomide) for use on the NHS, it has emerged, alongside Genentech’s Rituxan (rituximab), …
News
nice_new_london_office_internal_3_web

NICE rejects Roche’s Polivy combo in relapsed or refractory diffuse large B-cell lymphoma

February 26, 2020 Manufacturing and Production, Research and Development, Sales and Marketing NHS, NICE, Polivy, Roche

It has been revealed that UK drug watchdog NICE has chosen to reject Roche’s Polivy (polatuzumab vedotin), used alongside rituximab …
News
scotland

Scotland’s life sciences sector on track to break $8 billion by 2025

February 25, 2020 Manufacturing and Production, Sales and Marketing Scotland, UK, life sciences, pharma

A new report from the Scottish Government has revealed that the country’s life sciences sector is on track to breeze …
News

FDA greenlights first oral, daily, non-statin therapy for lowering LDL-Cholesterol

February 25, 2020 Manufacturing and Production, Sales and Marketing Esperion, FDA, Nexletol, pharma

Esperion’s ATP Citrase Lyase (ACL) inhibitor Nexletol (bempedoic acid) has secured approval from the FDA, it has emerged. It is …
News
160x100

2020 Veeva Unified Clinical Operations Survey

February 24, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing pharma, survey, veeva

Every year, Veeva asks clinical professionals to take part in the Veeva Unified Clinical Operations Survey to help the industry …
Feature
holly_springs_9frontflags

FDA approves first adjuvanted quadrivalent flu vaccine in over-65s

February 24, 2020 Sales and Marketing FDA, flu, influenza, pharma, seqirus

The FDA has just authorised its first adjuvanted quadrivalent influenza vaccine, it has been announced. Seqirus’ Fluad Quadrivalent (influenza vaccine, adjuvanted) …
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026